晚期糖基化终末产物受体的可溶性水平（sRAGE）与冠状动脉疾病：下一个C反应蛋白？ - Suppr

Suppr

超能文献

Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?

作者信息

Hudson Barry I, Harja Evis, Moser Bernhard, Schmidt Ann Marie

出版信息

Arterioscler Thromb Vasc Biol. 2005 May;25(5):879-82. doi: 10.1161/01.ATV.0000164804.05324.8b.

DOI:10.1161/01.ATV.0000164804.05324.8b

PMID:15863717

Abstract

摘要

相似文献

Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?

Arterioscler Thromb Vasc Biol. 2005 May;25(5):879-82. doi: 10.1161/01.ATV.0000164804.05324.8b.

Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.

J Crohns Colitis. 2014 Jun;8(6):513-20. doi: 10.1016/j.crohns.2013.11.004. Epub 2013 Dec 2.

Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.

Atherosclerosis. 2009 Dec;207(2):597-602. doi: 10.1016/j.atherosclerosis.2009.06.003. Epub 2009 Jun 11.

Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.

Nutr Res. 2014 Jun;34(6):478-85. doi: 10.1016/j.nutres.2014.04.012. Epub 2014 Apr 24.

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome.

Biomed Res Int. 2015;2015:815942. doi: 10.1155/2015/815942. Epub 2015 Sep 30.

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity.

J Crohns Colitis. 2011 Oct;5(5):402-6. doi: 10.1016/j.crohns.2011.03.011. Epub 2011 Apr 15.

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.

Microvasc Res. 2008 May;76(1):52-6. doi: 10.1016/j.mvr.2007.09.004. Epub 2007 Oct 5.

Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products.

Atherosclerosis. 2008 Mar;197(1):217-23. doi: 10.1016/j.atherosclerosis.2007.03.027. Epub 2007 May 17.

Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE auto-antibodies interfere with sRAGE quantification?

Ann Clin Biochem. 2014 Mar;51(Pt 2):248-57. doi: 10.1177/0004563213493402. Epub 2013 Aug 27.

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) may reflect tissue RAGE expression in diabetes.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):e32; author reply e33-4. doi: 10.1161/ATVBAHA.107.139923.

引用本文的文献

Soluble receptor for advanced glycation end products and its role in cardiovascular risk assessment in hyperglycemia - A study in North India.

J Family Med Prim Care. 2025 Apr;14(4):1325-1332. doi: 10.4103/jfmpc.jfmpc_1356_24. Epub 2025 Apr 25.

The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.

Respir Res. 2024 Feb 9;25(1):85. doi: 10.1186/s12931-024-02698-1.

Role of RAGE in obesity-induced adipose tissue inflammation and insulin resistance.

Cell Death Discov. 2021 Oct 22;7(1):305. doi: 10.1038/s41420-021-00711-w.

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia.

JAMA Netw Open. 2021 Jan 4;4(1):e2033012. doi: 10.1001/jamanetworkopen.2020.33012.

The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease.

Dis Markers. 2019 Jun 2;2019:4528382. doi: 10.1155/2019/4528382. eCollection 2019.

Advanced glycation end products and risk of hypertension in Iranian adults: Tehran lipid and glucose study.

J Res Med Sci. 2018 May 30;23:43. doi: 10.4103/jrms.JRMS_982_17. eCollection 2018.

A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.

Cancer Med. 2018 May;7(5):2180-2191. doi: 10.1002/cam4.1426. Epub 2018 Mar 23.

Serum soluble receptor of advanced glycation end products and risk of metabolic syndrome in Egyptian obese women.

EXCLI J. 2017 Jun 29;16:973-980. doi: 10.17179/excli2017-275. eCollection 2017.

Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease.

Aorta (Stamford). 2013 Aug 1;1(3):210-7. doi: 10.12945/j.aorta.2013.13-047. eCollection 2013 Aug.

Rutin Inhibits Neuroinflammation and Provides Neuroprotection in an Experimental Rat Model of Subarachnoid Hemorrhage, Possibly Through Suppressing the RAGE-NF-κB Inflammatory Signaling Pathway.

Neurochem Res. 2016 Jun;41(6):1496-504. doi: 10.1007/s11064-016-1863-7. Epub 2016 Feb 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?

作者信息

Hudson Barry I, Harja Evis, Moser Bernhard, Schmidt Ann Marie

出版信息

Arterioscler Thromb Vasc Biol. 2005 May;25(5):879-82. doi: 10.1161/01.ATV.0000164804.05324.8b.

DOI:10.1161/01.ATV.0000164804.05324.8b

PMID:15863717

Abstract

摘要

相似文献

Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?

Arterioscler Thromb Vasc Biol. 2005 May;25(5):879-82. doi: 10.1161/01.ATV.0000164804.05324.8b.

Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.

J Crohns Colitis. 2014 Jun;8(6):513-20. doi: 10.1016/j.crohns.2013.11.004. Epub 2013 Dec 2.

Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.

Atherosclerosis. 2009 Dec;207(2):597-602. doi: 10.1016/j.atherosclerosis.2009.06.003. Epub 2009 Jun 11.

Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.

Nutr Res. 2014 Jun;34(6):478-85. doi: 10.1016/j.nutres.2014.04.012. Epub 2014 Apr 24.

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome.

Biomed Res Int. 2015;2015:815942. doi: 10.1155/2015/815942. Epub 2015 Sep 30.

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity.

J Crohns Colitis. 2011 Oct;5(5):402-6. doi: 10.1016/j.crohns.2011.03.011. Epub 2011 Apr 15.

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.

Microvasc Res. 2008 May;76(1):52-6. doi: 10.1016/j.mvr.2007.09.004. Epub 2007 Oct 5.

Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products.

Atherosclerosis. 2008 Mar;197(1):217-23. doi: 10.1016/j.atherosclerosis.2007.03.027. Epub 2007 May 17.

Soluble form of receptor for advanced glycation end-products (sRAGE): do sRAGE ligands or anti-sRAGE auto-antibodies interfere with sRAGE quantification?

Ann Clin Biochem. 2014 Mar;51(Pt 2):248-57. doi: 10.1177/0004563213493402. Epub 2013 Aug 27.

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) may reflect tissue RAGE expression in diabetes.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):e32; author reply e33-4. doi: 10.1161/ATVBAHA.107.139923.

引用本文的文献

Soluble receptor for advanced glycation end products and its role in cardiovascular risk assessment in hyperglycemia - A study in North India.

J Family Med Prim Care. 2025 Apr;14(4):1325-1332. doi: 10.4103/jfmpc.jfmpc_1356_24. Epub 2025 Apr 25.

The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.

Respir Res. 2024 Feb 9;25(1):85. doi: 10.1186/s12931-024-02698-1.

Role of RAGE in obesity-induced adipose tissue inflammation and insulin resistance.

Cell Death Discov. 2021 Oct 22;7(1):305. doi: 10.1038/s41420-021-00711-w.

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia.

JAMA Netw Open. 2021 Jan 4;4(1):e2033012. doi: 10.1001/jamanetworkopen.2020.33012.

The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease.

Dis Markers. 2019 Jun 2;2019:4528382. doi: 10.1155/2019/4528382. eCollection 2019.

Advanced glycation end products and risk of hypertension in Iranian adults: Tehran lipid and glucose study.

J Res Med Sci. 2018 May 30;23:43. doi: 10.4103/jrms.JRMS_982_17. eCollection 2018.

A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.

Cancer Med. 2018 May;7(5):2180-2191. doi: 10.1002/cam4.1426. Epub 2018 Mar 23.

Serum soluble receptor of advanced glycation end products and risk of metabolic syndrome in Egyptian obese women.

EXCLI J. 2017 Jun 29;16:973-980. doi: 10.17179/excli2017-275. eCollection 2017.

Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease.

Aorta (Stamford). 2013 Aug 1;1(3):210-7. doi: 10.12945/j.aorta.2013.13-047. eCollection 2013 Aug.

Rutin Inhibits Neuroinflammation and Provides Neuroprotection in an Experimental Rat Model of Subarachnoid Hemorrhage, Possibly Through Suppressing the RAGE-NF-κB Inflammatory Signaling Pathway.

Neurochem Res. 2016 Jun;41(6):1496-504. doi: 10.1007/s11064-016-1863-7. Epub 2016 Feb 11.